[Sigmoid colon cancer during the course of a patient with multiple myeloma (IgG Kappa)].

Y. Iizuka,T. Sugiyama,T. Fuzita,T. Takanashi,T. Suzuki,Y. Kosaka,J. Murakami,T. Shindo,I. Amaki

1983-05-01

Abstract:

What problem does this paper attempt to address?

The blood pressure targets in sepsis patients with acute kidney injury: An observational cohort study of multiple ICUs

Lina Zhao,Yan Fan,Zhiwei Wang,Zhiyong Wei,Ying Zhang,Yun Li,Keliang Xie

DOI: https://doi.org/10.3389/fimmu.2022.1060612

2022-12-15

Abstract:Background: The maintenance of blood pressure is pivotal in preventing sepsis with acute kidney injury (AKI). Especially in sepsis patients treated with vasopressors. The optimal the blood pressure has been controversial to maintain renal perfusion. This study aims to explore the blood pressure target in sepsis with AKI. Methods: We retrieved patient data from the MIMIC IV and eICU databases. The Lasso regression model was used to identify the relationship between blood pressure and sepsis in patients with AKI and remove collinearity among variables. Generalized additive models were used to estimate the blood pressure range in patients with sepsis with AKI. Statistical methods such as multivariable logistic regression, propensity score analysis, inversion probability-weighting, and doubly robust model estimation were used to verify the target blood pressure for patients with sepsis and AKI. Results: In total, 17874 patients with sepsis were included in this study. the incidence of AKI may be related to the level of mean article pressure (MAP) and diastolic blood pressure (DBP) in sepsis patients. The range of MAPs and DBPs may be 65-73 mmHg and 50-60 mmHg in AKI patients without hypertension. The range of MAPs and DBPs may be 70-80 mmHg and 54-62 mmHg in AKI patients with hypertension. The prognosis of sepsis with AKI was unaffected by MAP or DBP. Systolic blood pressure is not associated with sepsis in patients with AKI. Conclusions: To ensure renal perfusion, AKI patients with hypertension may require a higher MAP [70-80] versus (65-73), mmHg] and DBP [(54-62) vs (50-60), mmHg] than patients without hypertension.
Clinical significance of first‐trimester chorionic bumps: a matched case–control study

Y. Sana,A. Appiah,A. Davison,Kypros H. Nicolaides,Jemma Johns,Jackie Ross

DOI: https://doi.org/10.1002/uog.12528

2013-11-01

Ultrasound in Obstetrics and Gynecology

Abstract:To determine the clinical significance of a chorionic bump diagnosed by ultrasound in women attending an early pregnancy unit in a teaching hospital.
Recent advances in the pharmacological management of sepsis-associated acute kidney injury

Kambiz Kalantari,Mitchell H Rosner

DOI: https://doi.org/10.1080/17512433.2021.1978287

2021-09-14

Expert Review of Clinical Pharmacology

Abstract:Acute kidney injury is a common occurrence in patients with sepsis and portends a high mortality as well as increased morbidity with numerous sequelae including the development of chronic kidney disease. Currently, there are no specific therapies that either prevent AKI or hasten its recovery. Thus, clinicians typically rely on management of the underlying infection, optimization of hemodynamic parameters as well as avoidance of nephrotoxins to maximize outcomes.Recent advances in understanding the mechanisms of sepsis as well as how these pathways may interact to lead to acute kidney injury have opened the door to the development of new, targeted therapies. This review focuses on the operative pathways in sepsis that have been identified as critical in leading to acute kidney injury and associated therapeutic agents that target these pathways.Despite increased understanding of the pathogenesis of sepsis, development of effective therapeutics to decrease the incidence of AKI have lagged. This is likely due to the complex pathophysiology with overlapping pathways and need for multiple therapies guided by specific biomarkers. Biomarkers that detail operative pathways may be able to guide the institution of more specific therapies with the hope for improved outcomes.

pharmacology & pharmacy
Biomarkers, Diagnosis and Management of Sepsis-Induced Acute Kidney Injury: a Narrative Review.

Zhongheng Zhang

2015-01-01

Abstract:Sepsis is a leading cause of acute kidney injury in clinical practice. The diagnosis of sepsis-induced acute kidney injury requires the diagnosis of sepsis and subsequent occurrence of acute kidney injury. The current definition for acute kidney injury is based on Scr and urine output, which is limited by the delayed identification of such patients. Numerous novel biomarkers have been found to be up-regulated in kidney injury, among which cystatin C and neutrophil gelatinase-associated lipocalin are the most studied. In the management of sepsis-induced acute kidney injury, early goal directed therapy may be potentially useful, but requires further validation in large clinical trials. It is well known that fluid overload is harmful in septic patients with established acute kidney injury and should be avoided. Renal replacement therapy is the mainstay treatment for the severe form of sepsis-induced acute kidney injury. However, there is still no consensus on the definition of timing and dosing in clinical practice, and the optimal timing and dosing are still unknown.
[The Hemodynamic Characteristic and Prognosis Significance of Acute Kidney Injury Caused by Septic Shock].

Rong-li Yang,Xiao-ting Wang,Da-wei Liu

DOI: https://doi.org/10.3760/cma.j.issn.0578-1426.2009.09.002

2009-01-01

Abstract:OBJECTIVE To study the incidence of acute kidney injury (AKI) in patients with septic shock, evaluate the impact of AKI stage on the prognosis of septic shock and explore the role of hemodynamics in the incidence of AKI. METHODS We retrospectively investigated the patients of septic shock who had been placed pulmonary artery catheter (PAC) continuously admitted in Peking Union Medical College Hospital from January, 2001 to June, 2008. Mortality and incidence of AKI were compared between groups of different AKI stages, survival analysis and prognosis evaluation were performed. The impacts of hemodynamics on the incidence of AKI were studied. RESULTS Altogether 158 cases of septic shock were enrolled in this retrospective study. Of all the patients, the incidences of all AKI and stage 1 - 3 were 79.7% (126/158), 16.5% (26/158), 16.5% (26/158) and 46.8% (74/158) respectively; 45.6% (72/158) of all the patients needed renal alternative therapy. Ninety-four patients died within 28 days (59.5%). The mortality in the patients without AKI was 12.5%, while those with AKI and those at stages 1-3 of AKI were 38.5%, 69.2%, 83.8% and 71.4% (P < 0.05), with OR values at 4.38, 15.75, 36.17 and 17.50 respectively. The survival analysis showed that the survival rate decreased as AKI stage increasing. The ROC curve showed that the area under curve (AUC) was 0.811, with 95%CI at 0.738 - 0.883 (P < 0.001). The incidences of AKI in patients with different levels of mean arterial pressure (mAP) were 76.2% (90 - 100 mm Hg), 71.8% (80 - 90 mm Hg) and 94.4% (65 - 80 mm Hg) respectively. The incidences of AKI in patients with different levels of cardiac index (CI) were 76.7% (> 4.0 L x min(-1) x m(-2)), 71.2% (2.5 - 4.0 L x min(-1) x m(-2)) and 96.6% (< 2.5 L x min(-1) x m(-2)). CONCLUSION Septic shock is highly associated with AKI and has poor prognosis. AKI stage of AKI net is an independent predictor of prognosis of septic shock. The change of hemodynamics has an important role on the development of septic AKI. It's useful to decrease the incidence of AKI by elevating the blood pressure and CI, but super-normal goal won't work better.
Sepsis-induced AKI: From pathogenesis to therapeutic approaches

Fang-Fang He,Yu-Mei Wang,Yi-Yuan Chen,Wei Huang,Zi-Qi Li,Chun Zhang

DOI: https://doi.org/10.3389/fphar.2022.981578

IF: 5.6

2022-09-15

Frontiers in Pharmacology

Abstract:Sepsis is a heterogenous and highly complex clinical syndrome, which is caused by infectious or noninfectious factors. Acute kidney injury (AKI) is one of the most common and severe complication of sepsis, and it is associated with high mortality and poor outcomes. Recent evidence has identified that autophagy participates in the pathophysiology of sepsis-associated AKI. Despite the use of antibiotics, the mortality rate is still at an extremely high level in patients with sepsis. Besides traditional treatments, many natural products, including phytochemicals and their derivatives, are proved to exert protective effects through multiple mechanisms, such as regulation of autophagy, inhibition of inflammation, fibrosis, and apoptosis, etc. Accumulating evidence has also shown that many pharmacological inhibitors might have potential therapeutic effects in sepsis-induced AKI. Hence, understanding the pathophysiology of sepsis-induced AKI may help to develop novel therapeutics to attenuate the complications of sepsis and lower the mortality rate. This review updates the recent progress of underlying pathophysiological mechanisms of sepsis-associated AKI, focuses specifically on autophagy, and summarizes the potential therapeutic effects of phytochemicals and pharmacological inhibitors.

pharmacology & pharmacy
Sepsis-associated acute kidney injury - treatment standard.

J. Koyner,A. Zarbock,L. Forni,H. Gómez,P. Pickkers

DOI: https://doi.org/10.1093/ndt/gfad142

2023-07-03

Abstract:Sepsis is a host's deleterious response to infection, which could lead to life-threatening organ dysfunction. Sepsis-associated acute kidney injury (SA-AKI) is the most frequent organ dysfunction and is associated with increased morbidity and mortality. Sepsis contributes to approximately 50% of all AKI in critically ill adult patients. A growing body of evidence has unveiled key aspects of the clinical risk factors, pathobiology, response to treatment, and elements of renal recovery that have advanced our ability to detect, prevent, and treat SA-AKI. Despite these advancements, SA-AKI remains a critical clinical condition and a major health burden, and further studies are needed to diminish the short and long-term consequences of SA-AKI. We review the current treatment standards and discuss novel developments in the pathophysiology, diagnosis, outcome prediction, and management of SA-AKI.

Medicine
Recognition of adjustment disorder in college athletes: a case study.

D. Shell,A. Ferrante

DOI: https://doi.org/10.1097/00042752-199601000-00013

Abstract:The occurrence of a sports-related adjustment disorder can inhibit optimum athletic performance and scholastic achievement and impair the overall functioning of athletes. Physicians and trainers caring for athletic teams must maintain an acute awareness of the athlete's mental and physical well-being to detect subtle signs of a mood or psychological disturbance. The case of the collegiate basketball player discussed here exemplifies the subtle presentation and stages of an adjustment disorder with the predominant manifestation of depression mixed with anxiety and disordered conduct. This player's lack of participation in practice and game play led to a distorted view of his self-worth, which slowly eroded his ability to play basketball, attend classes, and enjoy previously pleasurable activities.
Vasopressor Therapy and Blood Pressure Management in the Setting of Acute Kidney Injury

Laurence W Busse,Marlies Ostermann

DOI: https://doi.org/10.1016/j.semnephrol.2019.06.006

Abstract:Acute kidney injury (AKI) is common in the setting of shock. Hemodynamic instability is a risk factor for the development of AKI, and pathophysiological mechanisms include loss of renal perfusion pressure and impaired microcirculation. Although restoration of mean arterial pressure (MAP) may mitigate the risk of AKI to some extent, evidence on this is conflicting. Also debatable is the optimal blood pressure needed to minimize the risk of kidney injury. A MAP of 65 mm Hg traditionally has been considered adequate to maintain renal perfusion pressure, and studies have failed to consistently show improved outcomes at higher levels of MAP. Therapeutic options to support renal perfusion consist of catecholamines, vasopressin, and angiotensin II. Although catecholamines are the most studied, they are associated with adverse events at higher doses, including AKI. Vasopressin and angiotensin II are noncatecholamine options to support blood pressure and may improve microcirculatory hemodynamics through unique mechanisms, including differential vasoconstriction of efferent and afferent arterioles within the nephron. Future areas of study include methods by which clinicians can measure renal blood flow in a macrocirculatory and microcirculatory way, a personalized approach to blood pressure management in septic shock using patient-specific measures of perfusion adequacy, and novel agents that may improve the microcirculation within the kidneys without causing adverse microcirculatory effects in other organs.
Effect of the Intensity of Continuous Renal Replacement Therapy in Patients with Sepsis and Acute Kidney Injury: a Single-Center Randomized Clinical Trial

Ping Zhang,Yi Yang,Rong Lv,Yuntao Zhang,Wenqing Xie,Jianghua Chen

DOI: https://doi.org/10.1093/ndt/gfr486

2011-01-01

Abstract:INTRODUCTION:Acute kidney injury (AKI) is a major complication in patients with sepsis and is an independent predictor of mortality. However, the optimal intensity of renal replacement therapy for such patients is still controversial. METHODS:From 1 January 2004 to 30 September 2009, we randomly assigned 280 patients with sepsis and AKI to continuous renal replacement therapy by high-volume hemofiltration (50 mL/kg/h, HVHF) or extra high-volume hemofiltration (85 mL/kg/h, EHVHF). The primary study outcome was death from any cause within 28, 60 and 90 days. Results were analyzed by univariate and multivariate methods and by Kaplan-Meier survival curves. RESULTS:A total of 141 patients were given EHVHF and 139 were given HVHF. The two groups had similar baseline characteristics and received treatment for an average of 9.38 days (EHVHF group) and 8.88 days (HVHF group). There were no significant differences between the groups in number of deaths at 28, 60 or 90 days. There were also no differences between the groups in renal outcome of survivors at 90 days. Multivariate analysis indicated that inotropic support by norepinephrine, time in hospital of >7 days, blood platelet count <8 × 10(9)/L, Acute Physiological and Chronic Health Evaluation (APACHE) II score >25, total bilirubin >100 μmol/L, prothrombin time >18 s, serum creatinine <250 μmol/L and blood urea nitrogen >20 mmol/L were independent risk factors for death at 90 days after initiation of renal replacement therapy. CONCLUSIONS:In patients with sepsis and AKI, increasing the intensity of renal replacement therapy from 50 (HVHF) to 85 mL/kg/h (EHVHF) had no effect on survival at 28 and 90 days.
Efficacy analysis of high-flux hemofiltration in the treatment of sepsis

Hong-yun LV,Ping ZHANG,Jiang-hua CHEN

DOI: https://doi.org/10.3760/cma.j.issn.1001-7097.2011.04.005

2011-01-01

Abstract:objective To analyze the risk factors of sepsis,and to elucidate the efficacy of high-flux hemofihration(HVHF)in the treatment of sepsis and the initiate opportunity of HVHF treatment on sepsis complicated with acute kidney injury(AKI). Methods Clinical data of 152patients with sepsis undergoing HVHF treatment were retrospectively analyzed.APACHE Ⅱ,APACHE Ⅲ and SAPS Ⅱ score evaluation before treatment and 24 h,48 h.72 h after treatment were performed.According to 28-day survival,patients were divided into survival group and death group.Clinical indicators before and 24 h,48 h,72 h after treatment were compared between groups.Risk factors influencing prognosis of patients were examined by multivariate regression analysis.Influence of AKI stages on prognosis of patients was studied. Resalts Lung and alimentary tract were the most frequent infection sites of sepsis.Twenty-eight days after HVHF treatment,74 patients (48.68%)survived,seventy-eight patients (51.32%)died among 152patients,and 4 patients(2.63%)needed sequent renal replacement therapy.Twenty-eight-day mortality was significantly lower than the mortality 88.78%±17.72%predicted by APACHE Ⅲ.APACHE Ⅱ,APACHE Ⅲ and SAPS Ⅱ Sscores decreased remarkably (P＜0.01) 24 hours after treatment.Age,number of dysfunctional organ,APACHE Ⅱ,APACHE Ⅲ,SAPS Ⅱ scores,undedying diseases,shock,AKI,severe acute pancreatitis,alimentary tract hemorrhage,cataphora and pressor agent were correlated with 28-d survival rate.Underlving diseases and APACHE Ⅲ were independent risk factors.Renal function recovery rate in AKI stage 1 was higher than that in AKI stage 2,3(P＜0.05).Twenty-eight-day mortality of patients without AKI was lower compared to AKI stage 1,2,3(P＜0.05),but 28-day mortality was not significantly different among AKI stage 1,2,3. Conclusions Prognosis of patients with sepsis is poor.HVHF can improve biochemical indicators and prognosis of patients effectively,and increase survival rate.Underlying diseases and APACHE Ⅲ are independent risk factors of 28-day mortality of sepsis patients.Twenty-eight-day mortality of non-AKI patients is obviously lower compared to AKI stage 1,2,3patients.AKI stage is correlated with 28-day renal function recovery rate,but not obviously correlated with 28-day mortality.
Case report 243. Cortical ossifying lipoma of femur.

E. Downey,A. Brower,R. B. Holt

Skeletal Radiology

Abstract:
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup

Alexander Zarbock,Mitra K. Nadim,Peter Pickkers,Hernando Gomez,Samira Bell,Michael Joannidis,Kianoush Kashani,Jay L. Koyner,Neesh Pannu,Melanie Meersch,Thiago Reis,Thomas Rimmelé,Sean M. Bagshaw,Rinaldo Bellomo,Vicenzo Cantaluppi,Akash Deep,Silvia De Rosa,Xose Perez-Fernandez,Faeq Husain-Syed,Sandra L. Kane-Gill,Yvelynne Kelly,Ravindra L. Mehta,Patrick T. Murray,Marlies Ostermann,John Prowle,Zaccaria Ricci,Emily J. See,Antoine Schneider,Danielle E. Soranno,Ashita Tolwani,Gianluca Villa,Claudio Ronco,Lui G. Forni

DOI: https://doi.org/10.1038/s41581-023-00683-3

IF: 42.439

2023-02-24

Nature Reviews Nephrology

Abstract:Sepsis-associated acute kidney injury (SA-AKI) is common in critically ill patients and is strongly associated with adverse outcomes, including an increased risk of chronic kidney disease, cardiovascular events and death. The pathophysiology of SA-AKI remains elusive, although microcirculatory dysfunction, cellular metabolic reprogramming and dysregulated inflammatory responses have been implicated in preclinical studies. SA-AKI is best defined as the occurrence of AKI within 7 days of sepsis onset (diagnosed according to Kidney Disease Improving Global Outcome criteria and Sepsis 3 criteria, respectively). Improving outcomes in SA-AKI is challenging, as patients can present with either clinical or subclinical AKI. Early identification of patients at risk of AKI, or at risk of progressing to severe and/or persistent AKI, is crucial to the timely initiation of adequate supportive measures, including limiting further insults to the kidney. Accordingly, the discovery of biomarkers associated with AKI that can aid in early diagnosis is an area of intensive investigation. Additionally, high-quality evidence on best-practice care of patients with AKI, sepsis and SA-AKI has continued to accrue. Although specific therapeutic options are limited, several clinical trials have evaluated the use of care bundles and extracorporeal techniques as potential therapeutic approaches. Here we provide graded recommendations for managing SA-AKI and highlight priorities for future research.

urology & nephrology
Immunoregulatory mechanism of acute kidney injury in sepsis: A Narrative Review

Shujun Sun,Rui Chen,Xiaoke Dou,Maosha Dai,Junhao Long,Yan Wu,Yun Lin

DOI: https://doi.org/10.1016/j.biopha.2022.114202

2023-01-08

Abstract:Sepsis acute kidney injury (SAKI) is a common complication of sepsis, accounting for 26–50 % of all acute kidney injury (AKI). AKI is an independent risk factor for increased mortality risk in patients with sepsis. The excessive inflammatory cascade reaction in SAKI is one of the main causes of kidney damage. Both the innate immune system and the adaptive immune system are involved in the inflammation process of SAKI. Under the action of endotoxin, neutrophils, monocytes, macrophages, T cells and other complex immune network reactions occur, and a large number of endogenous inflammatory mediators are released, resulting in the amplification and loss of control of the inflammatory response. The study of immune cells in SAKI will help improve the understanding of the immune mechanisms of SAKI, and will lay a foundation for the development of new diagnostic and therapeutic targets. This article reviews the role of known immune mechanisms in the occurrence and development of SAKI, with a view to finding new targets for SAKI treatment.

pharmacology & pharmacy,medicine, research & experimental
Understanding the efficiency of human perception.

Bialek,Zee

DOI: https://doi.org/10.1103/PHYSREVLETT.61.1512

IF: 8.6

1988-09-26

Physical Review Letters

Abstract:
Hemodynamic management of acute kidney injury

Daniel De Backer,Rocio Rimachi,Jacques Duranteau

DOI: https://doi.org/10.1097/mcc.0000000000001213

2024-11-07

Current Opinion in Critical Care

Abstract:To discuss the role of hemodynamic management in critically ill patients with acute kidney injury. Acute kidney injury (AKI) may be associated with persistent alterations in renal perfusion, even when cardiac output and blood pressure are preserved. The effects of interventions aiming at increasing renal perfusion are best evaluated by renal Doppler or contrast enhance ultrasound. However, limited data have been acquired with these techniques and the essential of the literature is based on surrogates of renal function such as incidence of use of renal replacement therapy. Fluids may increase renal perfusion but their effects are quite unpredictable and can be dissociated from their impact on cardiac output and arterial pressure. Inotropes can also be used in selected conditions. At the de-escalation phase, fluid withdrawal should be considered. Safe fluid withdrawal may be achieved when applied in selected patients with preserved tissue perfusion presenting signs of fluid intolerance. When applied, stopping rules should be set. Dobutamine, milrinone and levosimendan increase renal perfusion in AKI associated with cardiac failure or after cardiac surgery. However, the impact of these agents in sepsis is not well defined. Regarding vasopressors, norepinephrine is the first-line vasopressor agent, but vasopressin derivative may limit the requirement of renal replacement therapy. Angiotensin has promising effects in a limited size post-Hoc analysis of a RCT, but these data need to be confirmed. While correction of severe hypotension is associated with improved renal perfusion and function, the optimal mean arterial pressure (MAP) target level remains undefined, Systematic increase in MAP results in variable changes in renal perfusion. It sounds reasonable to individualize MAP target, paying attention to central venous and intraabdominal pressures, as well as to the response to an increase in MAP.

critical care medicine
Blood purification for sepsis: an overview

Ling Zhang,Yuying Feng,Ping Fu

DOI: https://doi.org/10.1093/pcmedi/pbab005

2021-02-25

Precision Clinical Medicine

Abstract:Abstract Sepsis is a life-threatening organ failure exacerbated by a maladaptive infection response from the host, and is one of the major causes of mortality in the intensive care unit. In recent decades, several extracorporeal blood purification techniques have been developed to manage sepsis by acting on both the infectious agents themselves and the host immune response. This research aims to summarize recent progress on extracorporeal blood purification technologies applied for sepsis, discuss unanswered questions on renal replacement therapy for septic patients, and present a decision-making strategy for practitioners.

medicine, research & experimental
[A multicenter clinical study of critically ill patients with sepsis complicated with acute kidney injury in Beijing: incidence, clinical characteristics and outcomes]

Na Gao,Meiping Wang,Li Jiang,Bo Zhu,Xiuming Xi

DOI: https://doi.org/10.3760/cma.j.cn121430-20240210-00124

Abstract:Objective: To investigate the epidemiological characteristics and prognosis of critically ill patients with sepsis combined with acute kidney injury (AKI) in intensive care unit (ICU) in Beijing, and to analyze the risk factors associated with in-hospital mortality among these critically ill patients. Methods: Data were collected from the Beijing AKI Trial (BAKIT) database, including 9 049 patients consecutively admitted to 30 ICUs in 28 tertiary hospitals in Beijing from March 1 to August 31, 2012. Patients were divided into non-AKI and non-sepsis group, AKI and non-sepsis group, non-AKI and sepsis group, AKI and sepsis group. Clinical data recorded included demographic characteristics, primary reasons for ICU admission, comorbidities, sequential organ failure assessment (SOFA), acute physiology and chronic health evaluation II(APACHE II) within 24 hours of ICU admission, physiological and laboratory indexes, treatment in the ICU, AKI staging based on the Kidney Disease: Improving Global Outcomes (KDIGO), as well as the prognostic indicators including length of stay in ICU, length of stay in hospital, ICU and in-hospital mortality. The primary endpoint was discharge or in-hospital death. Multivariate Logistic regression analysis was used to investigate the risk factors for hospital death in ICU patients. Kaplan-Meier survival curve was drawn to analyze the cumulative survival of ICU patients during hospitalization. Results: A total of 3 107 critically ill patients were ultimately enrolled, including 1 259 cases in the non-AKI and non-sepsis group, 931 cases in the AKI and non-sepsis group, 264 cases in the non-AKI and sepsis groups, and 653 cases in the AKI and sepsis group. Compared with the other three group, patients in the AKI and sepsis group were the oldest, had the lowest mean arterial pressure (MAP), and the highest APACHE II score, SOFA score, blood urea nitrogen (BUN), and serum creatinine (SCr) levels, and they also had the highest proportion of receiving mechanical ventilation, requiring vasopressor support, and undergoing renal replacement therapy (RRT), all P < 0.01. Of these 3 107 patients, 1 584 (51.0%) were diagnosed with AKI, and the incidence of AKI in patients with sepsis was significantly higher than in those without sepsis [71.2% (653/917) vs. 42.5% (931/2 190), P < 0.01]. The highest proportion of KDIGO 0 stage was observed in the non-sepsis group (57.5%), while the highest proportion of KDIGO 3 stage was observed in the sepsis group (32.2%). Within the same KDIGO stage, the mortality of patients with sepsis was significantly higher than that of non-sepsis patients (0 stage: 17.8% vs. 3.1%, 1 stage: 36.3% vs. 7.4%, 2 stage: 42.7% vs. 17.1%, 3 stage: 54.6% vs. 28.6%, AKI: 46.1% vs. 14.2%). The ICU mortality (38.7%) and in-hospital mortality (46.1%) in the AKI and sepsis group were significantly higher than those in the other three groups. Kaplan-Meier survival curves further showed that the cumulative survival rate of patients with AKI and sepsis during hospitalization was significantly lower than that of the other three groups (53.9% vs. 96.9%, 85.8%, 82.2%, Log-Rank: χ 2 = 379.901, P < 0.001). Subgroup analysis showed that among surviving patients, length of ICU stay and total length of hospital stay were significantly longer in the AKI and sepsis group than those in the other three groups (both P < 0.01). Multivariate regression analysis showed that age, APACHE II score and SOFA score within 24 hours of ICU admission, coronary heart disease, AKI, sepsis, and AKI combined with sepsis were independent risk factors for ICU mortality in patients (all P < 0.05). After adjusting for covariates, AKI, sepsis, and sepsis combined with AKI were significantly associated with higher ICU and in-hospital mortality, with the highest ICU mortality [adjusted odds ratio (OR) = 14.82, 95% confidence interval (95%CI) was 8.10-27.12; Hosmer-Lemeshow test: P = 0.816] and in-hospital mortality (adjusted OR = 7.40, 95%CI was 4.94-11.08; Hosmer-Lemeshow test: P = 0.708) observed in patients with sepsis combined with AKI. Conclusions: The incidence of AKI is high in sepsis patients, and those with both AKI and sepsis have a higher disease burden, more abnormalities in physiological and laboratory indicators, and significantly increased ICU and in-hospital mortality. Among surviving patients, the length of ICU stay and total length of hospital stay are also longer in the AKI and sepsis group. Age, APACHE II score and SOFA score within 24 hours of ICU admission, coronary heart disease, AKI, and sepsis are independent risk factors for in-hospital mortality in ICU patients.
Influencing Factors and Prevention of Sepsis or Acute Kidney Injury in 85 Patients with Severe Trauma

Hong Zhang,Dan Chen,Lihua Wang,Bing Li

DOI: https://doi.org/10.1155/2021/5754114

IF: 2.65

2021-01-01

Evidence-based Complementary and Alternative Medicine

Abstract:Severe trauma can cause systemic reactions, leading to massive bleeding, shock, asphyxia, and disturbance of consciousness. At the same time, patients with severe trauma are at high risk of sepsis and acute renal injury. The occurrence of complications will increase the difficulty of clinical treatment, improve the mortality rate, and bring heavy physical and mental burdens and economic pressure to patients and their families. It is of great clinical significance to understand the high risk factors of sepsis and AKI and actively formulate prevention and treatment measures. In this study, the clinical data of 85 patients with severe trauma were analyzed by univariate and multivariate logistic regression to identify the risk factors leading to sepsis or AKI and analyze the prevention and treatment strategies. The results showed that multiple injuries, APACHE II score on admission, SOFA score on admission, and mechanical ventilation were independent influencing factors of sepsis in patients with severe trauma, while hemorrhagic shock, APACHE II score on admission, CRRT, and sepsis were independent influencing factors of AKI in patients with severe trauma. Severe trauma patients complicated with sepsis or AKI will increase the risk of death. In the course of treatment, prevention and intervention should be given as far as possible to reduce the incidence of complications.
Blood purification therapies for septic acute kidney injury

Wenyan Yu,Shuai Ma,Feng Ding

DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2015.13.001

2015-01-01

Abstract:Septic acute kidney injury is the common complication in the critically ill patients with high morbidity and mortality. Blood purification techniques, such as high-volume hemofiltration (HVHF), coupled plasma hemofiltrationadsorption (CPFA), high cut-off hemofiltration, represent a class of therapies for sepsis that have gain promising pre-clinical and early clinical results, but have not yet been translated into routine clinical practice. There are several explanations for the lack of translation of experimental findings from blood purification studies into clinical practice. For example, the mechanism, timing, dosage, frequency of blood purification in the clinical setting remained unknown. We designed two new kinds of blood purification devices, EBR and SCD, for the treatment of sepsis. In animal models, both of the interventions could alter the natural history of sepsis. Though in the primary research stage, novel blood purification therapies have put forward new insights for the therapy of septic acute kidney injury.

[Sigmoid colon cancer during the course of a patient with multiple myeloma (IgG Kappa)].

The blood pressure targets in sepsis patients with acute kidney injury: An observational cohort study of multiple ICUs

Clinical significance of first‐trimester chorionic bumps: a matched case–control study

Recent advances in the pharmacological management of sepsis-associated acute kidney injury

Biomarkers, Diagnosis and Management of Sepsis-Induced Acute Kidney Injury: a Narrative Review.

[The Hemodynamic Characteristic and Prognosis Significance of Acute Kidney Injury Caused by Septic Shock].

Sepsis-induced AKI: From pathogenesis to therapeutic approaches

Sepsis-associated acute kidney injury - treatment standard.

Recognition of adjustment disorder in college athletes: a case study.

Vasopressor Therapy and Blood Pressure Management in the Setting of Acute Kidney Injury

Effect of the Intensity of Continuous Renal Replacement Therapy in Patients with Sepsis and Acute Kidney Injury: a Single-Center Randomized Clinical Trial

Efficacy analysis of high-flux hemofiltration in the treatment of sepsis

Case report 243. Cortical ossifying lipoma of femur.

Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup

Immunoregulatory mechanism of acute kidney injury in sepsis: A Narrative Review

Understanding the efficiency of human perception.

Hemodynamic management of acute kidney injury

Blood purification for sepsis: an overview

[A multicenter clinical study of critically ill patients with sepsis complicated with acute kidney injury in Beijing: incidence, clinical characteristics and outcomes]

Influencing Factors and Prevention of Sepsis or Acute Kidney Injury in 85 Patients with Severe Trauma

Blood purification therapies for septic acute kidney injury